Back to search

Article

<i>De novo</i> design of anti-variant COVID-19 Vaccine

2022-10-20

Abstract excerpt

Recent studies have shown the efficacy of hybrid SARS-COV-2 vaccines using wild-type nucleocapsid (N) and Spike (S) protein. We upgraded this strategy one step further using clinically proven spike protein by considering the delta and post-delta omicron variant of concern (VOC) mutations and nucleocapsid peptides conferring T-cell immunity. Nucleocapsid peptides are considered much better immunological replacement...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4d0ca71d-243b-5047-bfb7-ebc0afc1a2d5
DOI
10.1101/2022.10.20.513049
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
<i>De novo</i> design of anti-variant COVID-19 VaccineDOI 10.1101/2022.10.20.513049
Select a neighboring publication to make it the new centre.